Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised Multi-Center Study: Microfracturing With Chondro-Gide® for the Treatment of Isolated Cartilage Defects in the Knee Project-Nr.: 10830-003

NCT02993510 is registered in ClinicalTrials.gov with Geistlich Pharma AG as lead sponsor.

NCT NCT02993510
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02993510 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised Multi-Center Study: Microfracturing With Chondro-Gide® for the Treatment of Isolated Cartilage Defects in the Knee Project-Nr.: 10830-003
Lead sponsor
Geistlich Pharma AG
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2003
Completion date
July 31, 2016
Enrollment
67 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

cartilage injury, osteochondritis dissecans